MonTa Biosciences

MonTa Biosciences

Biotechnology Research Kongens Lyngby, Hovedstaden, Dk 11 employees NORDI
Employees
11
Contacts
2
Emails
2

MonTa Biosciences Overview

Headquarters
Kongens Lyngby, Hovedstaden, Dk
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
11
Founded
2015
Stock Symbol
NORDI
Funding
3.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About MonTa Biosciences

MonTa Biosciences is a clinical stage biotech company located in the DTU science park in Kgs. Lyngby, Copenhagen. Our lead candidate MBS8 is a novel TLR7 agonist formulated in micelles, which show greater therapeutic activity and better safety profiles compared to non-formulated TLR7 agonists. We are currently running a phase I clinical study in solid tumor cancer patients at sites in Denmark, Belgium and Spain and have dosed more than 20 patients. MBS8 has the unique selling points: -MBS8 can turn “Cold” tumors into “Hot” tumors -Strong anti-tumor activity in a broad range of tumor models -Unique MoA based on Neutrophil activation and tumor cell killing -Can be administered intravenously -Show synergy with PD-1/PD-L1 checkpoint inhibitors Get in touch for more info

MonTa Biosciences Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

MonTa Biosciences Org Chart

Sample employees and titles
Name Title Contact
Soren Tulstrup
View
Morten Just Petersen Chief Development Officer at Monta
Email
Simon Skjøde Jensen CEO at Monta Biosciences
Email
Jonas R. Henriksen Associate Professor & Head of Section
View

Employees by Management Level

Executive 2 profiles
VP / Head 1 profile
Individual contributor 1 profile

Compare Similar Companies to MonTa Biosciences